Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)
China flag China · Delayed Price · Currency is CNY
23.50
+0.12 (0.51%)
At close: Feb 3, 2026

SHE:300702 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
388.14592.87426.15476.98476.751,296
Trading Asset Securities
0.08---72.9437.91
Cash & Short-Term Investments
388.22592.87426.15476.98549.71,334
Cash Growth
-21.60%39.12%-10.66%-13.23%-58.80%794.97%
Accounts Receivable
649.13594.26583.07455.15489.08443.07
Other Receivables
3.361.985.016.46.229.3
Receivables
652.49596.24588.09461.56495.3452.36
Inventory
1,8511,8811,8902,0171,599994.84
Other Current Assets
73.0759.3947.3861.95188.71129.56
Total Current Assets
2,9653,1292,9513,0182,8322,911
Property, Plant & Equipment
2,9312,8212,7932,8102,4651,663
Long-Term Investments
146.498889.8587.5778.6110.06
Other Intangible Assets
420.06408.77374.8366.82374.75241.34
Long-Term Deferred Tax Assets
13.7715.088.2515.86159.05
Long-Term Deferred Charges
38.8261.3577.5760.543.551.17
Other Long-Term Assets
49.2554.8943.3857.2731.4953.55
Total Assets
6,5646,5796,3386,4165,8014,890
Accounts Payable
841.94961.08803.061,3581,173803.6
Accrued Expenses
78.86161.08118.32140.45138.02105.04
Short-Term Debt
1,4061,6081,5251,066422.96232.93
Current Portion of Long-Term Debt
90.598448.7446.579.05-
Current Portion of Leases
-9.448.969.2914.27-
Current Income Taxes Payable
16.40.2317.32--46.44
Current Unearned Revenue
25.5823.5418.1641.1346.9417.28
Other Current Liabilities
32.4116.1623.788.593.5624.42
Total Current Liabilities
2,4922,8632,5632,6701,8771,230
Long-Term Debt
239.33102.69187.36143.297.1248.06
Long-Term Leases
31.1132.3328.7821.8723.85-
Long-Term Unearned Revenue
68.8567.9564.4169.1970.9250.83
Long-Term Deferred Tax Liabilities
7.278.891.499.3813.96.88
Other Long-Term Liabilities
5.475.585.0778.157.34
Total Liabilities
2,8443,0812,8502,9212,0911,343
Common Stock
347.98347.98347.98347.98347.98182.22
Additional Paid-In Capital
1,4251,4111,4561,4901,493724.14
Retained Earnings
1,9841,7811,7421,7151,8691,761
Treasury Stock
-30.39-34.95-58-58--14.18
Comprehensive Income & Other
-6.66-6.66-0.14-0.14-0.14893.92
Shareholders' Equity
3,7203,4983,4883,4953,7093,547
Total Liabilities & Equity
6,5646,5796,3386,4165,8014,890
Total Debt
1,7671,8361,7991,287637.26280.99
Net Cash (Debt)
-1,379-1,243-1,373-810.23-87.561,053
Net Cash Growth
-----886.81%
Net Cash Per Share
-3.98-3.56-4.01-2.32-0.253.24
Filing Date Shares Outstanding
356.66343.93343.93347.98347.98328
Total Common Shares Outstanding
356.66343.93345.57347.98347.98328
Working Capital
473.35265.8388.06347.65954.761,681
Book Value Per Share
10.4310.1710.0910.0410.6610.81
Tangible Book Value
3,3003,0893,1133,1283,3343,305
Tangible Book Value Per Share
9.258.989.018.999.5810.08
Buildings
-1,1181,0561,000798.58619.24
Machinery
-2,8732,6462,3161,8311,243
Construction In Progress
-327.76298.59439.07556.36396.13
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.